18
Views
5
CrossRef citations to date
0
Altmetric
Review

Evaluation and management of headache in primary care

Pages 425-437 | Published online: 10 Jan 2014

References

  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7), 1–96 (1988).
  • Headache Classification Subcommittee of the International Headache Society. International Classification of Headache Disorders. Second Edition. Cephalalgia 24(Suppl. 1), 1–160 (2004).
  • ••Includes explicit diagnostic criteria for allclassified headache disorders.
  • Ferrari MD. Migraine. Lancet 351, 1043–1051 (1998).
  • Smetana GW. The diagnostic value of historical features in primary headache syndromes: a comprehensive review. Anh. Intern Med. 160,2729–2737 (2000).
  • Steiner TJ, Fontebasso M. Headache. BE Med 325,881–886 (2002).
  • Kellgren JH. Observations on referred pain arising from muscle. Clin. Li. 3,175–190 (1938).
  • Srikiatkhachom A, Phanthurachinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 37,277–280 (1997).
  • Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 39, 190–196 (1999).
  • Limmroth V, Kazarawa Z, Fritsche G, Diener HC. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 353,378 (1999).
  • Steiner T Daily grind. Chemist Druggist 253(Suppl. 5–8), 6225 (2000).
  • Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 28,61–62 (1988).
  • Diener HC, Dichgans J, Scholz E et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J. Neural 236,9–14 (1989).
  • Coleman AL. Glaucoma. Lancet 354, 1803–1810 (1999).
  • UK Department of Health. Carbon Monoxide: The Forgotten Killer. Professional letter PUCM0/2002/2. Department of Health, London, UK (2002).
  • Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population — a prevalence study. J. Clin. Epidemial 44,1147–1157 (1991).
  • Rasmussen BK, Jensen R, Schroll M, Olesen J. Interrelations between migraine and tension-type headache in the general population. Arch. Ne1.1101 49,914-918 (1992).
  • Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19,602–621 (1999).
  • Steiner TJ, Scher AI, Stewart WF et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23,519–527 (2003).
  • Scher AI, Stewart WE Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 38,497–506 (1998).
  • World Health Organization. World health report 2001. World Health Organization, Geneva, Switzerland 22–24 (2001).
  • Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics2, 67–76 (1992).
  • Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache 34,344–350 (1994).
  • Rasmussen BK. Epidemiology of headache in Europe. In: Headache Classification and Epidemiology Olesen J (Ed.). Raven Press, NY, USA 231–237 (1994).
  • Stewart WF, Lipton RB, Simon D. Work- related disability: results from the American migraine study. Cephalalgia 16,231–238 (1996).
  • Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. Occupat. Environm. Med. 39,320–327 (1997).
  • Steiner TJ. Headache burdens and bearers. Funct. Neural 15 (Suppl. 3), 219–223 (2000).
  • Lipton RB, Bigal ME, Kolodner K et al. The family impact of migraine: population-based studies in the US and UK. Cephalalgia 23,429–440 (2003).
  • •Describes the effect of migraine on others than the person with migraine.
  • Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAIVIA 279,381–383 (1998).
  • Hopkins A, Menken M, De Friese GA. A record of patient encounters in neurological practice in the United Kingdom. J. Neural Neurosurg. Psychiat. 52,436–438 (1989).
  • Wiles CM, Lindsay M. General practice referrals to a department of neurology. J. Roy Coll Physicians 30,426–431 (1996).
  • Lipton RB, Scher AI, Steiner TJ et al. Patterns of healthcare utilization for migraine in England and in the United States. Neurology60, 441–448 (2003).
  • Laughey WF, Holmes WF, MacGregor AE, Sawyer JPC. Headache consultation and referral patterns in one UK general practice. Cephalalgia 19,328–329 (1999).
  • Hopkins A. Neurological services and the neurological health of the population in the United Kingdom. J. Neural Neurosurg. Psychiat. 63,553–559 (1997).
  • World Health Organization. Headache disorders and public health. Education and management implications. World Health Organization, Geneva, Swizerland (2000).
  • •Sets out World Health Organizations interest in headache disorders as a public health concern.
  • American Association for the Study of Headache, International Headache Society. Consensus statement on improving migraine management. Headache 38,736 (1998).
  • •Describes the problem of under-recognition and undertreatrnent of migraine.
  • Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch. Int. Med. 152,1273–1278 (1992).
  • Dowson A, Jagger S. The UK Migraine Patient Survey: quality of life and treatment. CUI7: Med. Res. Opin. 15, 241–253 (1999).
  • Edmeads J, Findlay H, Tugwell P, Pryse- Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour and medication use: a Canadian population study. Can. Neuml. Sci. 20,131-137 (1993).
  • Lipton RB, Amatniek JC, Ferrari MD, Gross M. Migraine: identifying and removing barriers to care. Neurology 44(Suppl. 4), S63—S68 (1994).
  • Mainous AG, Baker R, Love MM, Gray DP, Gill JM. Continuity of care and trust in one's physician: evidence from primary care in the United States and the United Kingdom. Family Med. 33,22–27 (2001).
  • Diener HC, Dichgans J, Scholz E et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J. Neural 236,9–14 (1989).
  • Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 17,73–80 (1997).
  • Chabriat H, Joire JE, Danchot J, Grippon P, Bousser mg. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study. Cephalalgia 14,297–300 (1994).
  • Tfelt-Hansen P, Henry P, Mulder LJ et al. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346,923–926 (1995).
  • •Demonstrates the efficacy of symptomatic (nontriptan) treatment for migraine in about half of those treated.
  • MacGregor EA. Menstruation, sex hormones and headache. Neural Clin. 15, 125–141 (1997).
  • Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 23,59–66 (2003).
  • Rothrock JE Clinical studies of valproate for migraine prophylaxis. Cephalalgia 17, 81–83 (1997).
  • Tfelt-Hansen P, Edvinsson L, Olesen J. Treatment of migraine with calcium entry blockers. Ping-. Basic Clin. Pharmacol 2, 143–154 (1989).
  • Gabai IJ, Spierings ELH. Prophylactic treament of cluster headache with verapamil. Headache 29,167–168 (1989).
  • Bussone G, Leone M, Peccarisi C et al Double-blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 30,411–417 (1990).
  • Couch JR, Ziegler DK. Prednisone therapy for cluster headache. Headache 18, 219–221(1978).
  • Kudrow L. Lithium prophylaxis for chronic cluster headache. Headache 17,15–18 (1977).
  • Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 21,132–139 (1981).
  • Manzoni GC, Bono G, Lanfranchi M et al. Lithium carbonate in cluster headache: assessment of its short- and long-term therapeutic efficacy. Cephalalgia 3, 109–114 (1983).
  • Horton BT Histaminic cephalgia. Lancet2, 92–98 (1952).
  • Symonds C. A particular variety of headache. Brain 79,217–232 (1956).
  • Lovshin LL. Treatment of histaminic cephalgia with methysergide (UML-491). Dir. Nerv Syst. 24,3-7 (1963).
  • Curran DA, Hinterberger H, Lance JW. Methysergide. Res. Clin. Stud. Headache 1, 74–122 (1967).
  • Kudrow L. Treatment of cluster headache. Headache Quart 4,42–47 (1993).
  • Duarte RA, Thornton DR. Short-acting analgesics may aggravate chronic headache pain. Am Fain. Physician 203 (1995).
  • Schnider P, Aull S, Bau mgartner C et al. Long-term outcome of patients with headache and drug abuse after in-patient withdrawal: five-year follow-up. Cephalalgia 16,481–485 (1996).
  • Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 337, 1442–1443 (1991).
  • Tfelt-Hansen P, McEwen J. Nonsteroidal anti-inflammatory drugs in the acute treatment of migraine. In: The Headaches. Second Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds). Lippincott-Raven, PA, USA, 391–397 (2000).
  • Rapoport A, Ryan R, Goldstein J, Keywood C. Dose range-finding studies with frovatriptan in the acute treatment of migraine. Headache 42 (Suppl. 2), S74—S83 (2002).
  • Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless but once-daily regimens are better. Cephalalgia 18,52–56 (1998).
  • Graham JR. Cardiac and pulmonary fibrosis during methysergide therapy for headaches. Am. J: Med. Li. 245,23-34 (1967).
  • Steiner TJ, Ferrari MD. Prophylaxis, patients' needs and neglected market opportunities. Cephalalgia 17,226 (1997).
  • Steiner TJ. Lifting the burden: the global campaign against headache. Lancet Neural. 3,204–205 (2004).
  • Frishberg BM, Rosenberg JH, Matchar DB et al Evidence-based guidelines in the primary care setting: neuroimaging in patients with nonacute headache. American Academy of Neurology (2001). www.aan.com/public (Accessed April 2004)
  • British Association for the Study of Headache. Guidelines for all doctors in the diagnosis and management of migraine and tension-type headache. BASH (2001). www.bash.org.uk (Accessed April 2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.